Multiple Sclerosis News Today Forums › Forums › Trials and Research › Study Looks at Long-Term Use of Gilenya by MS Patients

  • Trials and Research

    Study Looks at Long-Term Use of Gilenya by MS Patients

    Posted by ms-news-today-moderator on March 6, 2019 at 10:11 am

    Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found. Read more about this study and its findings here.

    Are you taking Gilenya? What has your experience been like so far?

    replied 5 years, 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .